Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

  • Resul Kahraman, Turan Calhan, Abdurrahman Sahin, Kamil Ozdil, Zuhal Caliskan, Elif Sinem Bireller, Bedia Cakmakoglu
  • Therapeutics and Clinical Risk Management, September 2017, Dove Medical Press
  • DOI: 10.2147/tcrm.s140618

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/tcrm.s140618

The following have contributed to this page: Professor BEDIA CAKMAKOGLU and Abdurrahman Sahin